483
Amphastar Nanjing Pharmaceuticals IncAmphastar Nanjing Pharmaceuticals Inc – FDA 483, Oct 10, 2019
Record Details
An FDA inspection of Amphastar Nanjing Pharmaceuticals, Inc. in Nanjing, China, revealed a deficiency in their annual visual inspection of retention samples. The firm's procedure and practice only included inspection of packaging, labeling, location, and quantity, but not the product itself. The company initiated corrective action during the inspection by updating their SOP to include product inspection.
View Company Profile
ID · 1b722d28-3603-4fae-a123-76b1bd4c8cb7
Other documents for Amphastar Nanjing Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.